The burgeoning field of metabolic management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These innovative therapies represent a https://tessyjxb245340.azuria-wiki.com/1951719/glp_3_receptor_agonists_retatrutide_trizepatide